1. Home
  2. ARTC vs CGC Comparison

ARTC vs CGC Comparison

Compare ARTC & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ARTC

Art Technology Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$10.01

Market Cap

349.4M

Sector

N/A

ML Signal

N/A

Logo Canopy Growth Corporation

CGC

Canopy Growth Corporation

N/A

Current Price

$0.63

Market Cap

299.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARTC
CGC
Founded
2025
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
349.4M
299.0M
IPO Year
2025
2023

Fundamental Metrics

Financial Performance
Metric
ARTC
CGC
Price
$10.01
$0.63
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $1.88
AVG Volume (30 Days)
19.2K
★ 2.6M
Earning Date
N/A
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 84.17
EPS
★ N/A
N/A
Revenue
N/A
★ $12,759,000.00
Revenue This Year
N/A
$17.89
Revenue Next Year
N/A
$8.58
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.79
$0.58
52 Week High
$10.05
$2.38

Technical Indicators

Market Signals
Indicator
ARTC
CGC
Relative Strength Index (RSI) 50.68 32.83
Support Level $9.96 N/A
Resistance Level $10.05 $1.08
Average True Range (ATR) 0.01 0.05
MACD -0.00 0.00
Stochastic Oscillator 42.86 24.13

Price Performance

Historical Comparison
ARTC
CGC

About ARTC Art Technology Acquisition Corp. Class A Ordinary Shares

Art Technology Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses.

About CGC Canopy Growth Corporation

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

Share on Social Networks: